image
Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 89.22
-1.69 %
$ 4.48 B
Market Cap
37.02
P/E
1. INTRINSIC VALUE

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system.[ Read More ]

The intrinsic value of one HAE stock under the base case scenario is HIDDEN Compared to the current market price of 89.2 USD, Haemonetics Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart HAE

image
FINANCIALS
1.31 B REVENUE
12.01%
165 M OPERATING INCOME
5.67%
118 M NET INCOME
1.87%
182 M OPERATING CASH FLOW
-33.44%
-322 M INVESTING CASH FLOW
-124.21%
38.2 M FINANCING CASH FLOW
138.02%
346 M REVENUE
2.78%
51.7 M OPERATING INCOME
16.49%
33.8 M NET INCOME
-11.84%
48.8 M OPERATING CASH FLOW
278.05%
-23.4 M INVESTING CASH FLOW
83.21%
-74.8 M FINANCING CASH FLOW
-22.42%
Balance Sheet Decomposition Haemonetics Corporation
image
Current Assets 769 M
Cash & Short-Term Investments 179 M
Receivables 207 M
Other Current Assets 384 M
Non-Current Assets 1.43 B
Long-Term Investments -9.41 M
PP&E 367 M
Other Non-Current Assets 1.07 B
Current Liabilities 300 M
Accounts Payable 73.4 M
Short-Term Debt 10.2 M
Other Current Liabilities 217 M
Non-Current Liabilities 935 M
Long-Term Debt 856 M
Other Non-Current Liabilities 79.7 M
EFFICIENCY
Earnings Waterfall Haemonetics Corporation
image
Revenue 1.31 B
Cost Of Revenue 633 M
Gross Profit 677 M
Operating Expenses 527 M
Operating Income 165 M
Other Expenses 47.3 M
Net Income 118 M
RATIOS
51.68% GROSS MARGIN
51.68%
12.60% OPERATING MARGIN
12.60%
8.98% NET MARGIN
8.98%
12.25% ROE
12.25%
5.35% ROA
5.35%
7.22% ROIC
7.22%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Haemonetics Corporation
image
Net Income 118 M
Depreciation & Amortization 97.2 M
Capital Expenditures -66.3 M
Stock-Based Compensation 28.3 M
Change in Working Capital -74.7 M
Others -10.6 M
Free Cash Flow 115 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Haemonetics Corporation
image
Wall Street analysts predict an average 1-year price target for HAE of $108 , with forecasts ranging from a low of $85 to a high of $120 .
HAE Lowest Price Target Wall Street Target
85 USD -4.73%
HAE Average Price Target Wall Street Target
108 USD 21.33%
HAE Highest Price Target Wall Street Target
120 USD 34.50%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Haemonetics Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
3.24 M USD 4
6-9 MONTHS
219 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Jul 26, 2024
Sell 393 K USD
Strong Stewart W
President, Global Hospital
- 4312
91.15 USD
4 months ago
Jul 11, 2024
Sell 192 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 2136
90 USD
4 months ago
Jul 12, 2024
Sell 7.11 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 79
90 USD
5 months ago
May 29, 2024
Sell 782 K USD
Basil Michelle L
EVP and General Counsel
- 8896
87.86 USD
5 months ago
May 29, 2024
Sell 363 K USD
Basil Michelle L
EVP and General Counsel
- 4094
88.57 USD
5 months ago
May 29, 2024
Sell 775 K USD
Strong Stewart W
President, Global Hospital
- 8857
87.53 USD
5 months ago
May 20, 2024
Sell 65.2 K USD
Strong Stewart W
President, Global Hospital
- 686
95.11 USD
5 months ago
May 20, 2024
Sell 93.8 K USD
Llorens Josep
EVP, Global Manufacturing
- 987
95.08 USD
6 months ago
May 17, 2024
Sell 77.9 K USD
Llorens Josep
EVP, Global Manufacturing
- 822
94.82 USD
5 months ago
May 20, 2024
Sell 153 K USD
Basil Michelle L
EVP and General Counsel
- 1604
95.08 USD
6 months ago
May 17, 2024
Sell 102 K USD
Basil Michelle L
EVP and General Counsel
- 1073
95 USD
6 months ago
May 16, 2024
Sell 70.4 K USD
Strong Stewart W
President, Global Hospital
- 733
96.04 USD
6 months ago
May 16, 2024
Sell 94.7 K USD
Basil Michelle L
EVP and General Counsel
- 985
96.14 USD
6 months ago
May 16, 2024
Sell 74 K USD
Llorens Josep
EVP, Global Manufacturing
- 770
96.14 USD
6 months ago
May 06, 2024
Sell 219 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 2305
95 USD
1 year ago
Sep 11, 2023
Sell 207 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 2305
90 USD
1 year ago
Sep 12, 2023
Sell 20.7 K USD
Strong Stewart W
President, Global Hospital
- 228
90.65 USD
1 year ago
Sep 05, 2023
Sell 896 K USD
Dockendorff Charles J
Director
- 10215
87.68 USD
1 year ago
Jul 18, 2023
Sell 444 K USD
Llorens Josep
EVP, Global Manufacturing
- 4928
90 USD
1 year ago
Jun 07, 2023
Sell 223 K USD
Strong Stewart W
President, Global Hospital
- 2538
88.04 USD
1 year ago
May 30, 2023
Sell 192 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 2304
83.33 USD
1 year ago
Jan 23, 2023
Sell 215 K USD
Llorens Josep
EVP, Global Manufacturing
- 2391
90 USD
2 years ago
Oct 24, 2022
Sell 6.03 K USD
Strong Stewart W
President, Global Hospital
- 75
80.39 USD
2 years ago
Oct 24, 2022
Sell 14.5 K USD
Basil Michelle L
EVP and General Counsel
- 180
80.39 USD
2 years ago
Sep 19, 2022
Sell 897 K USD
Basil Michelle L
EVP and General Counsel
- 11448
78.36 USD
2 years ago
Sep 19, 2022
Sell 16.2 K USD
Miller Laurie A.
SVP, Human Resources
- 212
76.25 USD
2 years ago
Sep 15, 2022
Sell 2.16 M USD
Basil Michelle L
EVP and General Counsel
- 27769
77.76 USD
2 years ago
Sep 15, 2022
Sell 473 K USD
Basil Michelle L
EVP and General Counsel
- 6029
78.5 USD
2 years ago
Sep 06, 2022
Sell 7.45 K USD
Llorens Josep
EVP, Global Manufacturing
- 101
73.78 USD
2 years ago
Aug 15, 2022
Sell 591 K USD
KROLL MARK W
director:
- 8016
73.71 USD
2 years ago
Jul 05, 2022
Sell 2.78 K USD
Miller Laurie A.
SVP, Human Resources
- 42
66.18 USD
2 years ago
Jun 13, 2022
Sell 1.88 K USD
Miller Laurie A.
SVP, Human Resources
- 30
62.6 USD
2 years ago
Jun 13, 2022
Sell 2.63 K USD
Goldstein Dan
VP, Corporate Controller
- 42
62.6 USD
2 years ago
Jun 13, 2022
Sell 17.3 K USD
Basil Michelle L
EVP and General Counsel
- 277
62.6 USD
2 years ago
Jun 13, 2022
Sell 71.9 K USD
Simon, Christopher
President & CEO
- 1148
62.6 USD
2 years ago
Jun 02, 2022
Sell 15.6 K USD
Goldstein Dan
VP, Corporate Controller
- 249
62.69 USD
2 years ago
Jun 02, 2022
Sell 12.4 K USD
Miller Laurie A.
SVP, Human Resources
- 198
62.69 USD
2 years ago
May 19, 2022
Sell 64.1 K USD
Strong Stewart W
President, Global Hospital
- 1084
59.1 USD
2 years ago
May 19, 2022
Sell 148 K USD
Simon, Christopher
President & CEO
- 2496
59.1 USD
2 years ago
May 19, 2022
Sell 5.38 K USD
Miller Laurie A.
SVP, Human Resources
- 91
59.1 USD
2 years ago
May 19, 2022
Sell 83.8 K USD
Llorens Josep
EVP, Global Manufacturing
- 1418
59.1 USD
2 years ago
May 19, 2022
Sell 81.8 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 1384
59.1 USD
2 years ago
May 19, 2022
Sell 7.92 K USD
Goldstein Dan
VP, Corporate Controller
- 134
59.1 USD
2 years ago
May 19, 2022
Sell 193 K USD
Basil Michelle L
EVP and General Counsel
- 3258
59.1 USD
2 years ago
May 16, 2022
Sell 1.74 K USD
Miller Laurie A.
SVP, Human Resources
- 31
56.1 USD
2 years ago
May 16, 2022
Sell 6 K USD
Llorens Josep
EVP, Global Manufacturing
- 107
56.1 USD
2 years ago
May 16, 2022
Sell 2.8 K USD
Goldstein Dan
VP, Corporate Controller
- 50
56.1 USD
2 years ago
May 16, 2022
Sell 11 K USD
Basil Michelle L
EVP and General Counsel
- 196
56.1 USD
2 years ago
May 16, 2022
Sell 46.7 K USD
Simon, Christopher
President & CEO
- 832
56.1 USD
2 years ago
Apr 18, 2022
Sell 10.7 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 189
56.55 USD
3 years ago
Oct 25, 2021
Sell 5.39 K USD
Strong Stewart W
President, Global Hospital
- 75
71.93 USD
3 years ago
Oct 25, 2021
Sell 8.63 K USD
Basil Michelle L
EVP and General Counsel
- 120
71.93 USD
3 years ago
Sep 07, 2021
Sell 6.46 K USD
Llorens Josep
EVP, Global Manufacturing
- 100
64.61 USD
3 years ago
Aug 23, 2021
Sell 1.37 M USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 22667
60.51 USD
3 years ago
Jul 01, 2021
Sell 286 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 4293
66.6 USD
3 years ago
Jun 14, 2021
Sell 2.33 K USD
Goldstein Dan
VP, Corporate Controller
- 39
59.87 USD
3 years ago
Jun 14, 2021
Sell 11.7 K USD
Basil Michelle L
EVP and General Counsel
- 195
59.87 USD
3 years ago
Jun 14, 2021
Sell 11.4 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 190
59.87 USD
3 years ago
Jun 14, 2021
Sell 71.8 K USD
Simon, Christopher
President & CEO
- 1200
59.87 USD
3 years ago
Jun 07, 2021
Sell 4.46 K USD
Goldstein Dan
VP, Corporate Controller
- 81
55.09 USD
3 years ago
Jun 07, 2021
Sell 10.7 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 195
55.09 USD
3 years ago
Jun 07, 2021
Sell 24.3 K USD
Basil Michelle L
EVP and General Counsel
- 442
55.09 USD
3 years ago
Jun 07, 2021
Sell 22.6 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 411
55.09 USD
3 years ago
Jun 07, 2021
Sell 150 K USD
Simon, Christopher
President & CEO
- 2715
55.09 USD
3 years ago
May 26, 2021
Sell 651 K USD
KROLL MARK W
Director
- 11813
55.1 USD
3 years ago
May 19, 2021
Sell 6.18 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 112
55.19 USD
3 years ago
May 19, 2021
Sell 2.32 K USD
Goldstein Dan
VP, Corporate Controller
- 42
55.19 USD
3 years ago
May 19, 2021
Sell 5.08 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 92
55.19 USD
3 years ago
May 19, 2021
Sell 6.9 K USD
Llorens Josep
SVP, Global Manufacturing
- 125
55.19 USD
3 years ago
May 19, 2021
Sell 12.1 K USD
Basil Michelle L
EVP and General Counsel
- 220
55.19 USD
3 years ago
May 19, 2021
Sell 13.1 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 238
55.19 USD
3 years ago
May 19, 2021
Sell 56.5 K USD
Simon, Christopher
President & CEO
- 1024
55.19 USD
3 years ago
May 17, 2021
Sell 2.35 K USD
Goldstein Dan
VP, Corporate Controller
- 42
55.97 USD
3 years ago
May 17, 2021
Sell 6.38 K USD
Llorens Josep
SVP, Global Manufacturing
- 114
55.97 USD
3 years ago
May 17, 2021
Sell 5.71 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 102
55.97 USD
3 years ago
May 17, 2021
Sell 11.4 K USD
Basil Michelle L
EVP and General Counsel
- 204
55.97 USD
3 years ago
May 17, 2021
Sell 12.3 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 219
55.97 USD
3 years ago
May 17, 2021
Sell 53.5 K USD
Simon, Christopher
President & CEO
- 956
55.97 USD
3 years ago
Apr 16, 2021
Sell 20.3 K USD
Lingamneni Anila
EVP, Chief Technology Officer
- 170
119.44 USD
3 years ago
Mar 08, 2021
Sell 12.8 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 107
120.07 USD
3 years ago
Mar 08, 2021
Sell 46.2 K USD
Basil Michelle L
EVP and General Counsel
- 385
120.07 USD
3 years ago
Feb 04, 2021
Sell 1.39 M USD
MEELIA RICHARD J
Director
- 10353
134.64 USD
3 years ago
Feb 04, 2021
Sell 1.64 M USD
Dockendorff Charles J
Director
- 12180
134.53 USD
3 years ago
Feb 04, 2021
Sell 198 K USD
Goldstein Dan
VP, Corporate Controller
- 1457
135.84 USD
3 years ago
Feb 04, 2021
Sell 64.7 K USD
Goldstein Dan
VP, Corporate Controller
- 476
135.88 USD
3 years ago
Feb 04, 2021
Sell 67.9 K USD
Goldstein Dan
VP, Corporate Controller
- 500
135.72 USD
3 years ago
Feb 04, 2021
Sell 32.4 K USD
Goldstein Dan
VP, Corporate Controller
- 238
136.26 USD
4 years ago
Oct 26, 2020
Sell 10.6 K USD
Goldstein Dan
VP, Corporate Controller
- 100
106 USD
4 years ago
Oct 26, 2020
Sell 123 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1161
106 USD
4 years ago
Oct 23, 2020
Sell 19.3 K USD
Basil Michelle L
EVP and General Counsel
- 181
106.58 USD
4 years ago
Sep 08, 2020
Sell 8.96 K USD
Llorens Josep
SVP, Global Manufacturing
- 101
88.71 USD
4 years ago
Aug 11, 2020
Bought 324 K USD
ABERNATHY ROBERT E
Director
+ 4000
80.93 USD
4 years ago
Jun 30, 2020
Sell 446 K USD
Simon, Christopher
President & CEO
- 5084
87.79 USD
4 years ago
Jun 12, 2020
Sell 18.1 K USD
Basil Michelle L
EVP and General Counsel
- 203
89.29 USD
4 years ago
Jun 15, 2020
Sell 928 K USD
Basil Michelle L
EVP and General Counsel
- 10578
87.71 USD
4 years ago
Jun 16, 2020
Sell 467 K USD
Basil Michelle L
EVP and General Counsel
- 5175
90.32 USD
4 years ago
Jun 16, 2020
Sell 636 K USD
Basil Michelle L
EVP and General Counsel
- 6961
91.34 USD
4 years ago
Jun 16, 2020
Sell 120 K USD
Basil Michelle L
EVP and General Counsel
- 1300
92.14 USD
4 years ago
Jun 12, 2020
Sell 17.6 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 197
89.29 USD
4 years ago
Jun 15, 2020
Sell 853 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 9720
87.71 USD
4 years ago
Jun 16, 2020
Sell 475 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 5259
90.36 USD
4 years ago
Jun 16, 2020
Sell 562 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 6146
91.38 USD
4 years ago
Jun 16, 2020
Sell 111 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1209
92.09 USD
4 years ago
Jun 12, 2020
Sell 3.46 K USD
Goldstein Dan
VP, Corporate Controller
- 42
82.29 USD
4 years ago
Jun 15, 2020
Sell 8.02 K USD
Goldstein Dan
VP, Corporate Controller
- 92
87.16 USD
4 years ago
Jun 15, 2020
Sell 112 K USD
Goldstein Dan
VP, Corporate Controller
- 1282
87.71 USD
4 years ago
Jun 16, 2020
Sell 278 K USD
Goldstein Dan
VP, Corporate Controller
- 3040
91.53 USD
4 years ago
Jun 12, 2020
Sell 9.91 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 111
89.29 USD
4 years ago
Jun 15, 2020
Sell 387 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 4417
87.71 USD
4 years ago
Jun 15, 2020
Sell 360 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 4005
90 USD
4 years ago
Jun 16, 2020
Sell 629 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 6869
91.53 USD
4 years ago
Jun 12, 2020
Sell 116 K USD
Simon, Christopher
President & CEO
- 1294
89.29 USD
4 years ago
Jun 15, 2020
Sell 4.01 M USD
Simon, Christopher
President & CEO
- 45723
87.71 USD
4 years ago
Jun 08, 2020
Sell 8.05 K USD
Goldstein Dan
VP, Corporate Controller
- 83
97.03 USD
4 years ago
Jun 08, 2020
Sell 110 K USD
Goldstein Dan
VP, Corporate Controller
- 1106
99.09 USD
4 years ago
Jun 09, 2020
Sell 18.2 K USD
Goldstein Dan
VP, Corporate Controller
- 187
97.19 USD
4 years ago
Jun 08, 2020
Sell 31.4 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 324
97.03 USD
4 years ago
Jun 08, 2020
Sell 66.7 K USD
Basil Michelle L
EVP and General Counsel
- 687
97.03 USD
4 years ago
Jun 08, 2020
Sell 62 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 639
97.03 USD
4 years ago
Jun 08, 2020
Sell 283 K USD
Simon, Christopher
President & CEO
- 2920
97.03 USD
4 years ago
May 15, 2020
Sell 101 K USD
Simon, Christopher
President & CEO
- 1008
100.44 USD
4 years ago
May 15, 2020
Sell 4.22 K USD
Goldstein Dan
VP, Corporate Controller
- 42
100.44 USD
4 years ago
May 18, 2020
Sell 10.3 K USD
Goldstein Dan
VP, Corporate Controller
- 101
101.72 USD
4 years ago
May 15, 2020
Sell 10.7 K USD
Llorens Josep
SVP, Global Manufacturing
- 107
100.44 USD
4 years ago
May 15, 2020
Sell 11 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 110
100.44 USD
4 years ago
May 15, 2020
Sell 20.4 K USD
Basil Michelle L
EVP and General Counsel
- 203
100.44 USD
4 years ago
May 15, 2020
Sell 22.2 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 221
100.44 USD
4 years ago
Apr 09, 2020
Sell 670 K USD
KROLL MARK W
Director
- 6573
102 USD
4 years ago
Apr 09, 2020
Sell 442 K USD
KROLL MARK W
Director
- 4329
102 USD
4 years ago
Apr 06, 2020
Sell 265 K USD
Goldstein Dan
VP, Corporate Controller
- 2607
101.62 USD
4 years ago
Apr 07, 2020
Sell 20.9 K USD
Goldstein Dan
VP, Corporate Controller
- 201
103.91 USD
4 years ago
Apr 08, 2020
Sell 38.8 K USD
Goldstein Dan
VP, Corporate Controller
- 399
97.12 USD
4 years ago
Mar 09, 2020
Sell 38.7 K USD
Basil Michelle L
EVP and General Counsel
- 395
98 USD
4 years ago
Mar 06, 2020
Sell 131 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1299
100.5 USD
4 years ago
Mar 09, 2020
Sell 11.6 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 118
98 USD
4 years ago
Mar 10, 2020
Sell 20.6 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 207
99.63 USD
5 years ago
Nov 11, 2019
Sell 40.1 K USD
Bolorforosh Said
EVP, Chief Technology Officer
- 339
118.27 USD
5 years ago
Nov 11, 2019
Sell 2 M USD
GELBMAN RONALD G
Director
- 16926
118.26 USD
5 years ago
Nov 11, 2019
Sell 777 K USD
MEELIA RICHARD J
Director
- 6573
118.15 USD
5 years ago
Oct 25, 2019
Sell 175 K USD
Goldstein Dan
VP, Corporate Controller
- 1456
120.32 USD
5 years ago
Oct 28, 2019
Sell 12 K USD
Goldstein Dan
VP, Corporate Controller
- 100
120.33 USD
5 years ago
Oct 29, 2019
Sell 29.1 K USD
Goldstein Dan
VP, Corporate Controller
- 237
122.69 USD
5 years ago
Oct 25, 2019
Sell 828 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 6905
119.87 USD
5 years ago
Oct 25, 2019
Sell 522 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 4326
120.65 USD
5 years ago
Oct 28, 2019
Sell 139 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1155
120.33 USD
5 years ago
Oct 29, 2019
Sell 178 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1448
122.69 USD
5 years ago
Oct 08, 2019
Sell 281 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 2295
122.34 USD
5 years ago
Oct 09, 2019
Sell 36.7 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 300
122.37 USD
5 years ago
Oct 09, 2019
Sell 152 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1230
123.57 USD
5 years ago
Oct 09, 2019
Sell 172 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1379
124.61 USD
5 years ago
Oct 08, 2019
Sell 1.09 M USD
Basil Michelle L
EVP and General Counsel
- 8883
122.34 USD
5 years ago
Oct 09, 2019
Sell 135 K USD
Basil Michelle L
EVP and General Counsel
- 1100
122.5 USD
5 years ago
Oct 09, 2019
Sell 460 K USD
Basil Michelle L
EVP and General Counsel
- 3724
123.5 USD
5 years ago
Oct 09, 2019
Sell 723 K USD
Basil Michelle L
EVP and General Counsel
- 5809
124.54 USD
5 years ago
Oct 08, 2019
Sell 2.32 M USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 18950
122.34 USD
5 years ago
Oct 09, 2019
Sell 356 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 2900
122.72 USD
5 years ago
Oct 09, 2019
Sell 1.03 M USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 8356
123.61 USD
5 years ago
Oct 09, 2019
Sell 1.43 M USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 11448
124.59 USD
5 years ago
Oct 01, 2019
Sell 382 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 3070
124.47 USD
5 years ago
Oct 01, 2019
Sell 165 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1309
125.71 USD
5 years ago
Oct 01, 2019
Sell 212 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 1670
126.72 USD
5 years ago
Oct 01, 2019
Sell 82.8 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 648
127.8 USD
5 years ago
Oct 01, 2019
Sell 60.1 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 467
128.66 USD
5 years ago
Sep 09, 2019
Sell 195 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1531
127.44 USD
5 years ago
Sep 05, 2019
Sell 13.1 K USD
Llorens Josep
SVP, Global Manufacturing
- 101
129.94 USD
5 years ago
Aug 30, 2019
Sell 87.9 K USD
Bolorforosh Said
EVP, Chief Technology Officer
- 657
133.73 USD
5 years ago
Aug 19, 2019
Sell 6.99 M USD
Simon, Christopher
President & CEO
- 50869
137.43 USD
5 years ago
Aug 08, 2019
Sell 228 K USD
GELBMAN RONALD G
Director
- 1696
134.15 USD
5 years ago
Aug 09, 2019
Sell 63.3 K USD
Goldstein Dan
VP, Corporate Controller
- 475
133.23 USD
5 years ago
Jul 01, 2019
Sell 610 K USD
Simon, Christopher
President & CEO
- 5008
121.79 USD
5 years ago
Jun 17, 2019
Sell 325 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 2890
112.49 USD
5 years ago
Jun 17, 2019
Sell 55.9 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 497
112.49 USD
5 years ago
Jun 17, 2019
Sell 29.1 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 259
112.49 USD
5 years ago
Jun 13, 2019
Sell 10.4 K USD
Goldstein Dan
VP, Corporate Controller
- 94
110.58 USD
5 years ago
Jun 12, 2019
Sell 4.27 K USD
Goldstein Dan
VP, Corporate Controller
- 39
109.37 USD
5 years ago
Jun 12, 2019
Sell 7.55 K USD
Bolorforosh Said
EVP, Chief Technology Officer
- 69
109.37 USD
5 years ago
Jun 12, 2019
Sell 11.8 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 108
109.37 USD
5 years ago
Jun 12, 2019
Sell 25.3 K USD
Basil Michelle L
EVP and General Counsel
- 231
109.37 USD
5 years ago
Jun 12, 2019
Sell 20.8 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 190
109.37 USD
5 years ago
Jun 12, 2019
Sell 136 K USD
Simon, Christopher
President & CEO
- 1248
109.37 USD
5 years ago
Jun 10, 2019
Sell 20 K USD
Goldstein Dan
VP, Corporate Controller
- 192
104.38 USD
5 years ago
Jun 06, 2019
Sell 114 K USD
Goldstein Dan
VP, Corporate Controller
- 1107
103.25 USD
5 years ago
Jun 07, 2019
Sell 8.06 K USD
Goldstein Dan
VP, Corporate Controller
- 78
103.38 USD
5 years ago
Jun 07, 2019
Sell 21.5 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 208
103.38 USD
5 years ago
Jun 06, 2019
Sell 635 K USD
Basil Michelle L
EVP and General Counsel
- 6148
103.25 USD
5 years ago
Jun 07, 2019
Sell 698 K USD
Basil Michelle L
EVP and General Counsel
- 6745
103.5 USD
5 years ago
Jun 07, 2019
Sell 45.7 K USD
Basil Michelle L
EVP and General Counsel
- 442
103.38 USD
5 years ago
Jun 07, 2019
Sell 42.5 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 411
103.38 USD
5 years ago
Jun 07, 2019
Sell 293 K USD
Simon, Christopher
President & CEO
- 2834
103.38 USD
5 years ago
May 23, 2019
Sell 2.43 M USD
Simon, Christopher
President & CEO
- 24412
99.39 USD
5 years ago
May 14, 2019
Sell 151 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1508
100 USD
5 years ago
May 13, 2019
Sell 5.44 M USD
Simon, Christopher
President & CEO
- 57587
94.51 USD
5 years ago
Apr 08, 2019
Sell 232 K USD
Goldstein Dan
VP, Corporate Controller
- 2607
88.93 USD
5 years ago
Apr 08, 2019
Sell 18.5 K USD
Goldstein Dan
VP, Corporate Controller
- 210
88.31 USD
5 years ago
Apr 09, 2019
Sell 34.6 K USD
Goldstein Dan
VP, Corporate Controller
- 389
88.99 USD
5 years ago
Mar 07, 2019
Sell 9.69 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 116
83.57 USD
5 years ago
Mar 07, 2019
Sell 32.7 K USD
Basil Michelle L
EVP and General Counsel
- 391
83.57 USD
5 years ago
Feb 15, 2019
Sell 709 K USD
GELBMAN RONALD G
Director
- 8196
86.52 USD
5 years ago
Dec 14, 2018
Sell 843 K USD
MEELIA RICHARD J
Director
- 8196
102.86 USD
5 years ago
Dec 14, 2018
Sell 446 K USD
GELBMAN RONALD G
Director
- 4329
103.02 USD
5 years ago
Dec 12, 2018
Sell 107 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 1027
104.22 USD
5 years ago
Dec 10, 2018
Sell 174 K USD
Goldstein Dan
VP, Corporate Controller
- 1693
102.91 USD
6 years ago
Nov 08, 2018
Sell 1.49 M USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 13056
114.33 USD
6 years ago
Nov 08, 2018
Sell 1.41 M USD
GRANADILLO PEDRO P
Director
- 12322
114.5 USD
6 years ago
Nov 07, 2018
Sell 1.22 M USD
KROLL MARK W
Director
- 10707
114 USD
6 years ago
Oct 26, 2018
Sell 79.2 K USD
Burke William P. Mr.
EVP, Chief Financial Officer
- 779
101.69 USD
6 years ago
Oct 26, 2018
Sell 10.4 K USD
Goldstein Dan
VP, Corporate Controller
- 102
101.69 USD
6 years ago
Sep 17, 2018
Sell 164 K USD
GRANADILLO PEDRO P
Director
- 1502
108.92 USD
6 years ago
Sep 17, 2018
Sell 407 K USD
GRANADILLO PEDRO P
Director
- 3696
110.11 USD
6 years ago
Sep 17, 2018
Sell 1.47 M USD
GRANADILLO PEDRO P
Director
- 13183
111.33 USD
6 years ago
Sep 17, 2018
Sell 1.34 M USD
GRANADILLO PEDRO P
Director
- 11812
113.16 USD
6 years ago
Sep 17, 2018
Sell 72 K USD
GRANADILLO PEDRO P
Director
- 631
114.16 USD
6 years ago
Sep 10, 2018
Sell 324 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 2889
112.19 USD
6 years ago
Sep 10, 2018
Sell 78.8 K USD
Scanlan Jacqueline
SVP, Global Human Resources
- 702
112.19 USD
7. News
HAE or BSX: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 day ago
Here's Why Haemonetics (HAE) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 4 days ago
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet The mean of analysts' price targets for Haemonetics (HAE) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 5 days ago
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025. zacks.com - 6 days ago
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics The headline numbers for Haemonetics (HAE) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates Haemonetics (HAE) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.99 per share a year ago. zacks.com - 1 week ago
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website Financial release accessible online BOSTON , Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. prnewswire.com - 1 week ago
Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Beyond analysts' top -and-bottom-line estimates for Haemonetics (HAE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024. zacks.com - 1 week ago
Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE Donidalorsen will be a first-in-class RNA-targeted medicine for hereditary angioedema, assuming approval Donidalorsen PDUFA date set for August 21, 2025 Donidalorsen has the potential to be Ionis' second independent commercial launch CARLSBAD, Calif. , Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational RNA-targeted medicine for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older. prnewswire.com - 1 week ago
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
HAE vs. BSX: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2 weeks ago
Intellia Therapeutics: Lower Stock Price On HAE Data Presents A Buying Opportunity Intellia Therapeutics, Inc. achieved positive phase 1/2 results using NTLA-2002 for HAE patients: 8 out of 11 patients taking higher doses of 50 mg of NTLA-2002 were attack-free during the 16-week primary observation period. Despite the stock price trading lower by 20%, the HAE treatment program continues on using NTLA-2002 in the phase 3 HAELO study. The global hereditary angioedema treatment market size is projected to reach $17.31 billion by the end of 2032. seekingalpha.com - 3 weeks ago
8. Profile Summary

Haemonetics Corporation HAE

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 4.48 B
Dividend Yield 0.00%
Description Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Contact 125 Summer Street, Boston, MA, 02110 https://www.haemonetics.com
IPO Date May 10, 1991
Employees 3657
Officers Ms. Farris Maryanne Maunsell Vice President, Chief Accounting Officer & Principal Accounting Officer Ms. Olga Guyette Senior Director of Investor Relations Mr. Josep Lluis Llorens Executive Vice President of Global Manufacturing & Supply Chain Mr. James C. D'Arecca CPA Chief Financial Officer, Executive Vice President & Financial Officer Mr. Rajeev Varma Senior Vice President of Strategy & Corporate Development Ms. Kerri DiPietro Senior Vice President of Global Quality Assurance Mr. Stewart W. Strong President of Global Hospital Ms. Laurie A. Miller Senior Vice President & Chief Human Resources Officer Dr. Jan Hartmann M.D. Senior Vice President & Chief Medical Officer Mr. Christopher A. Simon Chief Executive Officer, President & Director